Prognosis of Small Cell Lung Cancer with Idiopathic Pulmonary Fibrosis: Assessment according to GAP Stage

Myung Jin Song, Sung Yoon Lim, Jong Sun Park, Ho Il Yoon, Jae Ho Lee, Song Yee Kim, Ji Ye Jung, Young Ae Kang, Moo Suk Park, Young Sam Kim, Joon Chang, Sang Hoon Lee, Choon Taek Lee

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Introduction. Idiopathic pulmonary fibrosis (IPF) is an independent risk factor for lung cancer development, and small cell lung cancer (SCLC) comprises 15-20% of lung cancers with IPF. The objective of this study was to investigate survival outcomes and treatment-related complications according to GAP (gender, age, and physiology) stage in patients having SCLC with IPF (SCLC-IPF). Materials and Methods. Retrospectively collected data of SCLC-IPF patients from two tertiary care university hospitals in South Korea were reviewed. A total of 59 SCLC-IPF patients were identified and categorized according to GAP stage, which was proposed by Ley et al. in 2012 to predict the prognosis of IPF. Survival outcomes and treatment-related complications were compared between the two groups. Results. In a total of 59 patients, the median age was 71 years and 58 (98.3%) were male. In a comparison of the median overall survival (OS) according to GAP stage, median OS of the advanced GAP stage group was significantly shorter than median OS of GAP stage I group (7.1 months vs. 16.1 months; p = 0.002). Treatment-related complications occurred more frequently in the advanced GAP stage group; advanced GAP stage was the only predictor that exhibited a significant association with the incidence of acute exacerbation of IPF. Conclusions. Inferior survival outcome and higher incidence of treatment-related pulmonary toxicities were noted in the advanced GAP stage group. Furthermore, advanced GAP stage was the only predictor of treatment-related acute exacerbation of IPF. Physicians should thus consider GAP stage, which reflects the severity of IPF, during treatment of SCLC-IPF.

Original languageEnglish
Article number5437390
JournalJournal of Oncology
Volume2019
DOIs
Publication statusPublished - 2019

All Science Journal Classification (ASJC) codes

  • Oncology

Fingerprint Dive into the research topics of 'Prognosis of Small Cell Lung Cancer with Idiopathic Pulmonary Fibrosis: Assessment according to GAP Stage'. Together they form a unique fingerprint.

  • Cite this

    Song, M. J., Lim, S. Y., Park, J. S., Yoon, H. I., Lee, J. H., Kim, S. Y., Jung, J. Y., Kang, Y. A., Park, M. S., Kim, Y. S., Chang, J., Lee, S. H., & Lee, C. T. (2019). Prognosis of Small Cell Lung Cancer with Idiopathic Pulmonary Fibrosis: Assessment according to GAP Stage. Journal of Oncology, 2019, [5437390]. https://doi.org/10.1155/2019/5437390